CN110201150A - A kind of drug increasing the anti-HPV of human body cell activity - Google Patents

A kind of drug increasing the anti-HPV of human body cell activity Download PDF

Info

Publication number
CN110201150A
CN110201150A CN201910630800.4A CN201910630800A CN110201150A CN 110201150 A CN110201150 A CN 110201150A CN 201910630800 A CN201910630800 A CN 201910630800A CN 110201150 A CN110201150 A CN 110201150A
Authority
CN
China
Prior art keywords
human body
hpv
dosage
cell activity
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910630800.4A
Other languages
Chinese (zh)
Inventor
张萌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GUANGZHOU SHAMAN BIOTECHNOLOGY Co Ltd
Original Assignee
GUANGZHOU SHAMAN BIOTECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GUANGZHOU SHAMAN BIOTECHNOLOGY Co Ltd filed Critical GUANGZHOU SHAMAN BIOTECHNOLOGY Co Ltd
Priority to CN201910630800.4A priority Critical patent/CN110201150A/en
Publication of CN110201150A publication Critical patent/CN110201150A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/066—Clavicipitaceae
    • A61K36/068—Cordyceps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A61K36/355—Lonicera (honeysuckle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to pharmaceutical technology fields, the drug of the anti-HPV of increase human body cell activity a kind of is provided, includes reed reed grass, liquid mineral substance, cordyceps sinensis, Ganoderma Lucidum, Radix Ginseng Rubra, donkey-hide gelatin, west safflower, ginseng, organic Cranberry, Macfadyena unguis-cati (L.) A. Gentry, witch hazel, levisticum officinale root, naringin, aloe, Salvia japonica, organic Honeysuckle flower leaf, pot marigold and Hei Sang；Reed reed grass promotes estrogen secretion, increase estrogen secretory volume, improve female ovary function reduction, nutriment in liquid mineral substance is easy the activated cell activity that is absorbed by the body, tumour cell is purified, cordyceps sinensis inhibits growth and metastasis of tumours, and Radix Ginseng Rubra promotes impaired cell migration, it has solved genital wart caused by the HPV infection of high-risk-type and the low risk HPV infection of external genital organs and cervical carcinoma damage human skin has infectiousness, threatened the problem of patient and its family members' life safety.

Description

A kind of drug increasing the anti-HPV of human body cell activity
Technical field
The invention belongs to pharmaceutical technology fields, and in particular to a kind of drug for increasing the anti-HPV of human body cell activity.
Background technique
HPV viruse is the abbreviation of human papilloma virus, is that a kind of papilloma vacuolating virus A of papovaviridae belongs to, It is a kind of sexually transmitted disease caused by spherical DNA virus infection.
The HPV crowd infection rate of skin-type is very universal, such as verruca vulgaris, toe wart and verruca plana, the HPV infection of high-risk-type Genital wart caused by low risk HPV infection with external genital organs and cervical carcinoma damage human skin have infectiousness, threaten and suffer from Person and its family members' life safety.
Summary of the invention
The invention reside in providing the drug of the anti-HPV of increase human body cell activity a kind of, with solve high-risk-type HPV infection and Genital wart caused by the low risk HPV infection of external genital organs and cervical carcinoma damage human skin, threaten patient and its family members people The problem of raw safety.
The invention is realized in this way the present invention provides the drug of the anti-HPV of increase human body cell activity a kind of, it include 15g- 30g reed reed grass, 5g-15g liquid mineral substance, 10g-20g cordyceps sinensis, 20g-30g Ganoderma Lucidum, 5g-10g Radix Ginseng Rubra, 2g-6g donkey-hide gelatin, 5g-25g west safflower, 5g-10g ginseng, the organic Cranberry of 10g-20g, 5g-10g Macfadyena unguis-cati (L.) A. Gentry, 5g-10g witch hazel, 5g-10g circle Leaf angelica root, 5g-10g naringin, 5g-15g aloe, 5g-15g Salvia japonica, the organic Honeysuckle flower leaf of 5g-15g, 5g-15g pot marigold and The black mulberry of 5g-15g.
It preferably, further include 15g-20g L-vitamin C, wherein the L-vitamin C, cordyceps sinensis and Ganoderma Lucidum contain The sum of amount is no more than 70g.
Preferably, further include 5g-15g Bacillus acidi lactici, wherein the dosage of the Bacillus acidi lactici be less than Radix Ginseng Rubra, donkey-hide gelatin and The sum of dosage of west safflower.
It preferably, further include 5g-10g hyaluronic acid, wherein the hyaluronic acid, ginseng, organic Cranberry and Macfadyena unguis-cati (L.) A. Gentry The sum of dosage between 25g-45g.
Preferably, further include 2g-8g elastin, wherein the elastin, witch hazel and levisticum officinale root dosage The sum of be no more than 20g.
It preferably, further include 2g-5g isoflavones, wherein the sum of the isoflavones, naringin and dosage of aloe are no more than 25g。
Preferably, in the liquid mineral substance comprising iodine, Zn-ef ficiency, selenium element, copper, molybdenum element, chromium, Cobalt element and ferro element.
Compared with the existing methods, the beneficial effects of the present invention are: reed reed grass promotes estrogen secretion, pass through increase Estrogen secretory volume improves female ovary function reduction, and hormone, which lacks, brings to obtain various inferior health symptom, liquid mine Nutriment in substance is easy the activated cell activity that is absorbed by the body, and minerals and the intracorporal tumour cell generation ion of people are anti- It answers, purifies tumour cell, and carry out deep layer toxin expelling, enhance the ability of human erythrocyte Adhesion To Tumor Cells by cordyceps sinensis, inhibit Growth and metastasis of tumours promotes impaired cell migration by Radix Ginseng Rubra, improves skin quality, solved the HPV infection of high-risk-type Genital wart caused by low risk HPV infection with external genital organs and cervical carcinoma damage human skin have infectiousness, threaten and suffer from The problem of person and its family members' life safety.
Specific embodiment
The technical method in inventive embodiments will be clearly and completely described below, it is clear that described embodiment Only invention a part of the embodiment, instead of all the embodiments.Based on the embodiment in invention, ordinary skill people Member's every other embodiment obtained without making creative work, belongs to the range of invention protection.
Embodiment 1
The present invention provides the drug of the anti-HPV of increase human body cell activity a kind of, includes 15g-30g reed reed grass, 5g-15g liquid mine Substance, 10g-20g cordyceps sinensis, 20g-30g Ganoderma Lucidum, 5g-10g Radix Ginseng Rubra, 2g-6g donkey-hide gelatin, 5g-25g west safflower, 5g-10g people Ginseng, the organic Cranberry of 10g-20g, 5g-10g Macfadyena unguis-cati (L.) A. Gentry, 5g-10g witch hazel, 5g-10g levisticum officinale root, 5g-10g naringin, 5g-15g aloe, 5g-15g Salvia japonica, the organic Honeysuckle flower leaf of 5g-15g, 5g-15g pot marigold and the black mulberry of 5g-15g.
In the present embodiment, estrogen secretion is promoted by reed reed grass, improves women skin quality from the root, Female ovary function reduction is adjusted, hormone lacks brought all kinds of inferior health symptom, passes through liquid mineral substance human activin Cell activity, while liquid mineral substance generates ionic reaction with tumour cell in human body, purifies tumour cell and thin by tumour The normal cell of born of the same parents' pollution, and deep layer toxin expelling is carried out to cell, it is thin to enhance red blood cell adhesion tumour by the cordycepin in cordyceps sinensis The ability of born of the same parents, initial infection inactivate tumour cell by red blood cell, the later period are infected, by red blood cell to tumour cell Inhibition is generated, immunity of human body itself is improved by Ganoderma Lucidum, inhibits the breeding of tumour cell, human body blood is improved by west safflower The blood supply ability of liquid circulation, improves blood microcirculation, supplements blood, moisture and the nutrition of each cell in human body, reinforces In human body while the activity of red blood cell, pigment is adjusted in the precipitating of skin surface, wrinkle and melanin is reduced, makes skin more Exquisite luster is flexible.
In the present embodiment, the central nervous system of human body is adjusted by ginseng, is accelerated metabolism in human body, is passed through Accelerate human metabolism's circulation the intracorporal toxin of people will to be discharged in human body, a variety of pathogenic bacterias are inhibited by organic Cranberry Growth and breeding, prevention and control female reproductive system infection and inhibit Helicobacter pylori infection, maintain female reproduction The normal pH value of system.
It further, further include 15g-20g L-vitamin C, wherein the L-vitamin C, cordyceps sinensis and Ganoderma Lucidum The sum of content is no more than 70g.
In the present embodiment, the D-Glucose in plant can become vitamin C via invertase, be given birth to by left-handed dimension Plain C inhibits Tyrosinase and reduction melanin, and the spot desalinated to be formed, and inhibits melanin to be formed, promotes human collagen egg White synthesis reduces microgroove, if lacking L-vitamin C in human body be easy to cause cutis laxa aging, generate wrinkle, more aging The content of L-vitamin C contained by skin is fewer, therefore need to supplement at any time, when skin is influenced by external environment, will form free Free radical, free radical can destroy collagen, elastin in normal tissue, cause aging, generate microgroove and wrinkle, left-handed dimension Raw element C can effectively neutralize free radical, improve skin lines, restore impaired skin, make skin consolidation flexible, while increasing human body The elasticity of skin.
It further, further include 5g-15g Bacillus acidi lactici, wherein the dosage of the Bacillus acidi lactici is less than Radix Ginseng Rubra, donkey-hide gelatin The sum of with the dosage of west safflower.
In the present embodiment, Bacillus acidi lactici prevents invasion and field planting of the pathogen to enteron aisle, inhibits pathogen, anti-sense Dye maintains the intracorporal microecological balance of people, prevention and the generation for inhibiting tumour, enhances human body immunity of organisms, promotes digestion, closes At amino acid and vitamin, cholesterol is reduced, inhibits endotoxic production, is delayed senescence and anti-radiation and other effects, when human body intestines Bacillus acidi lactici quantity in road is reduced or is lost, and flora imbalance occurs, so that it may the generation for leading to certain disease, when the cream in enteron aisle Acidfast bacilli quantity increases, and fauna is balanced, so that it may promote human body body health and treatment disease.
It further, further include 5g-10g hyaluronic acid, wherein the hyaluronic acid, ginseng, organic Cranberry and ram's horn The sum of dosage of rattan is between 25g-45g.
In the present embodiment, hyaluronic acid is to constitute the connective tissues such as human body cell gap, vitreum, knuckle synovia Main component, in vivo play water conservation, maintain intraor extracellular space, adjust osmotic pressure, lubrication, promote cell repair it is important Physiological function contains a large amount of hydroxyl and carboxyl in hyaluronan molecule, forms intramolecular and intermolecular hydrogen in aqueous solution Key, this makes it have powerful water retention, and in combination with itself 400 times or more of water, hyaluronic acid is as intercellular matrix Main component, the directly regulation of participation intraor extracellular electrolyte exchange play the filter effect of physics and molecular information.Big point Sub- hyaluronic acid is mobile to cell, be proliferated, differentiation and phagocytic function have inhibiting effect, and micromolecule hyaluronic acid then has promotion to make With.
Further, further include 2g-8g elastin, wherein the elastin, witch hazel and levisticum officinale root use The sum of amount is no more than 20g.
In the present embodiment, elastin is the protein hydrolysate of a kind of water-insoluble, high intersection degree, elastin laminin molecule Middle nonpolar amino acid accounts for 95%, and for Glycine Levels close to the one third of total amount, proline accounts for 10%, and hydroxyproline accounts for 1%, bullet Power albumen is antiacid, basic hydrolysis, and 100 DEG C or less are broken solvent insoluble in a variety of hydrogen bonds, and are swollen, insoluble in phenol solvent. In addition to being broken peptide bond agent, it does not dissolve in any solvent.Elastin laminin is a kind of in the presence of water with rubber ductility and low bullet Property modulus polymer, elastomer coexists with collagenous fibres by elastin laminin, assign human connective tissue with elasticity and Expanding ability.
It further, further include 2g-5g isoflavones, wherein the sum of the isoflavones, naringin and dosage of aloe do not surpass Cross 25g.
In the present embodiment, isoflavones has a dual regulation, isoflavones be used as in chemistry analogue with Estrogenic activity is related, and display inhibits and bidirectional modulation effect of collaboration, and when human body inner estrogen is horizontal relatively low, isoflavones is accounted for According to estrogen receptor, weak estrogen effect is played, the effect for improving estrogen level is shown, when the horizontal mistake of human body inner estrogen Gao Shi, isoflavones occupy acceptor site, it is selective in conjunction with estrogen receptor and property mildly with brain, prostate, bladder, the heart The affinity of the receptors such as blood vessel and bone tissue is strong, weak to the affinity of uterus, ovary, mammary gland etc., while isoflavones activity only has The one thousandth of female hormone and ten a ten thousandths, thus avoid complementing estrogen and may induce the risk of cancer.
Further, iodine, Zn-ef ficiency, selenium element, copper, molybdenum element, chromium member are included in the liquid mineral substance Element, cobalt element and ferro element.
In the present embodiment, the microelements such as calcium, magnesium, potassium, sodium, phosphorus, sulphur and chlorine, micro member are included in liquid mineral substance Element content in body burden is few, but has powerful biological effect, directly the metabolic process of participation enzyme, hormone and accounting, Its physiological function is mainly shown as assistance conveying macroelement, constituent or activator of the microelement as enzyme, in hormone With unique effect is played in vitamin, nucleic acid metabolism etc. is influenced, by thin in the microelement human activin in liquid mineral substance Cytoactive, while the microelement in liquid mineral substance and the intracorporal tumour cell of people generate ionic reaction, improve human body cell Interior environment, the normal cell for purifying tumour cell and being polluted by tumour cell, and deep layer toxin expelling is carried out to cell.
In the present embodiment, the sum of dosage of L-vitamin, cordyceps sinensis and Ganoderma Lucidum is no more than 70g, the use of Ganoderma Lucidum The dosage for measuring compare L-vitamin and cordyceps sinensis is more, and Ganoderma Lucidum has antifatigue, anti-aging, beautifying face and moistering lotion, improves human body Immunity function, prevents tumour cell diffusive infection, the dosage of Bacillus acidi lactici be less than Radix Ginseng Rubra, donkey-hide gelatin and west safflower dosage it It is greater than the dosage of Bacillus acidi lactici with, the sum of dosage of Radix Ginseng Rubra, donkey-hide gelatin and west safflower, reduces Bacillus acidi lactici to Radix Ginseng Rubra, donkey-hide gelatin With the effect of west safflower, its resistance infection is improved while Bacillus acidi lactici maintains vagina self-cleaning, reduces HPV tumour Cellular invasion breeding, the sum of hyaluronic acid, organic Cranberry, ginseng and Macfadyena unguis-cati (L.) A. Gentry dosage between 25g-45g, hyaluronic acid, Organic Cranberry, ginseng and Macfadyena unguis-cati (L.) A. Gentry enhance human body immunity of organisms, while preventing tumour cell diffusion couple human skin from generating It influences, 20g is no more than by the sum of elastin, witch hazel and levisticum officinale root dosage, adjusts human body microgroove, reduces wrinkle, It is no more than 25g by the sum of isoflavones, naringin and dosage of aloe, improvement female menstrual period is unstable, and prevention improves due to bone Cancer caused by matter is loose.
Embodiment 2
As described in above-described embodiment 1, in the present embodiment,
It further, include 15g reed reed grass, 5g liquid mineral substance, 10g cordyceps sinensis, 20g Ganoderma Lucidum, 5g Radix Ginseng Rubra, 2g donkey-hide gelatin, 5g West safflower, 5g ginseng, the organic Cranberry of 10g, 5g Macfadyena unguis-cati (L.) A. Gentry, 5g witch hazel, 5g levisticum officinale root, 5g naringin, 5g aloe, 5g The organic Honeysuckle flower leaf of Salvia japonica, 5g, 5g pot marigold, the black mulberry of 5g, 15g L-vitamin C, 5g Bacillus acidi lactici, 5g hyaluronic acid, 2g bullet Power albumen and 2g isoflavones.
In the present embodiment, the sum of dosage of 15g L-vitamin, 10g cordyceps sinensis and 20g Ganoderma Lucidum is no more than 70g, The dosage of 20g Ganoderma Lucidum compare 15g L-vitamin and 10g cordyceps sinensis dosage it is more, Ganoderma Lucidum has antifatigue, anti-ageing Always, beautifying face and moistering lotion, raising human immunologic function, prevent tumour cell diffusive infection, and the dosage of 5g Bacillus acidi lactici is less than 5g rising star The sum of ginseng, 2g donkey-hide gelatin and dosage of 5g west safflower are greater than by the sum of setting 5g Radix Ginseng Rubra, 2g donkey-hide gelatin and dosage of 5g west safflower The dosage of 5g Bacillus acidi lactici reduces Bacillus acidi lactici and has an impact to Radix Ginseng Rubra, donkey-hide gelatin and west safflower, maintains vagina in Bacillus acidi lactici Its resistance infection is improved while self-cleaning, reduces the diffusion breeding of HPV tumour cell, the organic Cranberry of 5g hyaluronic acid, 10g, 5g Between 25g-45g, hyaluronic acid, organic Cranberry, ginseng and Macfadyena unguis-cati (L.) A. Gentry enhance human body for the sum of ginseng and 5g Macfadyena unguis-cati (L.) A. Gentry dosage Immunity of organisms, while preventing tumour cell diffusion couple human skin from having an impact, pass through 2g elastin, 5g witch hazel and 5g The sum of levisticum officinale root dosage is no more than 20g, adjusts human body microgroove, reduces wrinkle, passes through 2g isoflavones, 5g naringin and 5g reed The sum of dosage of luxuriant growth is no more than 25g, and improvement female menstrual period is unstable, and prevention improves the cancer as caused by osteoporosis.
Embodiment 3
As described in above-described embodiment 1, in the present embodiment,
It further, include 30g reed reed grass, 15 liquid mineral substances, 20g cordyceps sinensis, 30g Ganoderma Lucidum, 10g Radix Ginseng Rubra, 6g donkey-hide gelatin, 25 West safflower, 10g ginseng, the organic Cranberry of 20g, 5g Macfadyena unguis-cati (L.) A. Gentry, 10g witch hazel, 5g levisticum officinale root, 5g naringin, 15g reed Luxuriant growth, 15g Salvia japonica, the organic Honeysuckle flower leaf of 15g, 15g pot marigold, the black mulberry of 15g, 20g L-vitamin C, 15g Bacillus acidi lactici, 10g are saturating Bright matter acid, 5g elastin and 5g isoflavones.
In the present embodiment, the sum of dosage of 20g L-vitamin, 20g cordyceps sinensis and 30g Ganoderma Lucidum is no more than 70g, The dosage of 30g Ganoderma Lucidum compare 20g L-vitamin and 20g cordyceps sinensis dosage it is more, Ganoderma Lucidum has antifatigue, anti-ageing Always, beautifying face and moistering lotion, raising human immunologic function prevent tumour cell diffusive infection, and it is red that the dosage of 15g Bacillus acidi lactici is less than 10g The sum of ginseng, 6g donkey-hide gelatin and dosage of 25g west safflower pass through the sum of setting 5g Radix Ginseng Rubra, 2g donkey-hide gelatin and dosage of 5g west safflower It greater than the dosage of 5g Bacillus acidi lactici, reduces Bacillus acidi lactici and Radix Ginseng Rubra, donkey-hide gelatin and west safflower is had an impact, maintained in Bacillus acidi lactici Its resistance infection is improved while vagina self-cleaning, reduces the diffusion breeding of HPV tumour cell, while a large amount of uses of 25g west safflower Maintenance adjusting is carried out to the intracorporal blood of people, the blood oxygen supply capacity to promote blood circulation improves microcirculation in blood body, supplement Blood oxygen, moisture and the nutrition of human body cell, adjuster colour of skin element reduce human body wrinkle, 10g hyaluronic acid, 20g it is organic it is climing more Between 25g-45g, hyaluronic acid, organic Cranberry, ginseng and Macfadyena unguis-cati (L.) A. Gentry increase for the sum of the certain kind of berries, 10g ginseng and 5g Macfadyena unguis-cati (L.) A. Gentry dosage Strong man's body immunity of organisms, while preventing tumour cell diffusion couple human skin from having an impact, pass through 5g elastin, 10g gold The sum of thread plum and 5g levisticum officinale root dosage are no more than 20g, adjust human body microgroove, reduce wrinkle, pass through 5g isoflavones, 5g citrus The sum of dosage of glycosides and 15g aloe is no more than 25g, and improvement female menstrual period is unstable, and prevention improves as caused by osteoporosis Cancer.
It is understood that a variety of to the progress of these embodiments can change in the case where not departing from the principle and spirit of invention, Modification, replacement and variant, the range of invention are defined by the appended claims and the equivalents thereof.

Claims (7)

1. a kind of drug for increasing the anti-HPV of human body cell activity, it is characterised in that: include 15g-30g reed reed grass, 5g-15g liquid Minerals, 10g-20g cordyceps sinensis, 20g-30g Ganoderma Lucidum, 5g-10g Radix Ginseng Rubra, 2g-6g donkey-hide gelatin, 5g-25g west safflower, 5g-10g people Ginseng, the organic Cranberry of 10g-20g, 5g-10g Macfadyena unguis-cati (L.) A. Gentry, 5g-10g witch hazel, 5g-10g levisticum officinale root, 5g-10g naringin, 5g-15g aloe, 5g-15g Salvia japonica, the organic Honeysuckle flower leaf of 5g-15g, 5g-15g pot marigold and the black mulberry of 5g-15g.
2. a kind of drug for increasing the anti-HPV of human body cell activity according to claim 1, it is characterised in that: further include 15g-20g L-vitamin C, wherein the sum of content of the L-vitamin C, cordyceps sinensis and Ganoderma Lucidum is no more than 70g.
3. a kind of drug for increasing the anti-HPV of human body cell activity according to claim 1, it is characterised in that: further include 5g- 15g Bacillus acidi lactici, wherein the dosage of the Bacillus acidi lactici is less than the sum of Radix Ginseng Rubra, donkey-hide gelatin and dosage of west safflower.
4. a kind of drug for increasing the anti-HPV of human body cell activity according to claim 1, it is characterised in that: further include 5g- 10g hyaluronic acid, wherein the hyaluronic acid, ginseng, organic Cranberry and Macfadyena unguis-cati (L.) A. Gentry the sum of dosage between 25g-45g.
5. a kind of drug for increasing the anti-HPV of human body cell activity according to claim 1, it is characterised in that: further include 2g- 8g elastin, wherein the sum of dosage of the elastin, witch hazel and levisticum officinale root is no more than 20g.
6. a kind of drug for increasing the anti-HPV of human body cell activity according to claim 1, it is characterised in that: further include 2g- 5g isoflavones, wherein the sum of the isoflavones, naringin and dosage of aloe are no more than 25g.
7. a kind of drug for increasing the anti-HPV of human body cell activity according to claim 1, it is characterised in that: the liquid It include iodine, Zn-ef ficiency, selenium element, copper, molybdenum element, chromium, cobalt element and ferro element in minerals.
CN201910630800.4A 2019-07-12 2019-07-12 A kind of drug increasing the anti-HPV of human body cell activity Pending CN110201150A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910630800.4A CN110201150A (en) 2019-07-12 2019-07-12 A kind of drug increasing the anti-HPV of human body cell activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910630800.4A CN110201150A (en) 2019-07-12 2019-07-12 A kind of drug increasing the anti-HPV of human body cell activity

Publications (1)

Publication Number Publication Date
CN110201150A true CN110201150A (en) 2019-09-06

Family

ID=67797319

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910630800.4A Pending CN110201150A (en) 2019-07-12 2019-07-12 A kind of drug increasing the anti-HPV of human body cell activity

Country Status (1)

Country Link
CN (1) CN110201150A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115486538A (en) * 2022-09-14 2022-12-20 广州通泽医疗科技有限公司 Composition with female reproductive system protection effect and preparation method and application thereof

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1960743A (en) * 2003-04-16 2007-05-09 薰衣草作物项目有限公司 Herbal composition
CN101032607A (en) * 2007-03-31 2007-09-12 王成斌 Medicine for treating pointed condyloma
CN103041283A (en) * 2011-10-12 2013-04-17 薛晓鸥 Externally-used traditional Chinese medicine composition for treating cervical HPV infection and preparation method thereof
CN103341106A (en) * 2013-07-29 2013-10-09 北京百睿宏嘉生物科技有限公司 Cordyceps sinensis antisepsis and anti-inflammation gel and preparation method thereof
CN104042654A (en) * 2013-03-12 2014-09-17 江中药业股份有限公司 Application of composition in preparation of anti-HPV (human papillomavirus) health product or medicine or product
CN104839650A (en) * 2015-04-08 2015-08-19 劲膳美生物科技股份有限公司 Medical formula food for cervical cancer
CN107184911A (en) * 2017-06-19 2017-09-22 太原谷歌医药科技有限公司 One kind is used to prevent cervical carcinoma and treatment papillomavirus（HPV）Infection and the product and preparation method of colpitis
CN108186718A (en) * 2018-03-13 2018-06-22 余晓晴 A kind of gynaecology's spray prevented and inhibit HPV viruse
CN108542954A (en) * 2018-05-22 2018-09-18 湖南千金养生坊健康品股份有限公司 A kind of Traditional Chinese medicine gel composition of inhibitory anti-virus
CN108853287A (en) * 2018-08-07 2018-11-23 吉林省正肽生物科技有限公司 Pharmaceutical composition, gel preparation and the application of a kind of anti-human papilloma virus (anti-HPV) and anti-gynaecological imflammation
CN108976269A (en) * 2018-01-24 2018-12-11 李立 A method of high-purity aurantiin is quickly prepared from the fresh young fruit of shaddock
CN109106806A (en) * 2018-06-20 2019-01-01 广州宏韵医药科技股份有限公司 A kind of women secret nursing washing lotion and preparation method thereof
CN109674903A (en) * 2019-01-29 2019-04-26 罗梦芝 One curing hysteromyoma, uterus adenomyosis, cervical polyp, HPV therapeutic agent

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1960743A (en) * 2003-04-16 2007-05-09 薰衣草作物项目有限公司 Herbal composition
CN101032607A (en) * 2007-03-31 2007-09-12 王成斌 Medicine for treating pointed condyloma
CN103041283A (en) * 2011-10-12 2013-04-17 薛晓鸥 Externally-used traditional Chinese medicine composition for treating cervical HPV infection and preparation method thereof
CN104042654A (en) * 2013-03-12 2014-09-17 江中药业股份有限公司 Application of composition in preparation of anti-HPV (human papillomavirus) health product or medicine or product
CN103341106A (en) * 2013-07-29 2013-10-09 北京百睿宏嘉生物科技有限公司 Cordyceps sinensis antisepsis and anti-inflammation gel and preparation method thereof
CN104839650A (en) * 2015-04-08 2015-08-19 劲膳美生物科技股份有限公司 Medical formula food for cervical cancer
CN107184911A (en) * 2017-06-19 2017-09-22 太原谷歌医药科技有限公司 One kind is used to prevent cervical carcinoma and treatment papillomavirus（HPV）Infection and the product and preparation method of colpitis
CN108976269A (en) * 2018-01-24 2018-12-11 李立 A method of high-purity aurantiin is quickly prepared from the fresh young fruit of shaddock
CN108186718A (en) * 2018-03-13 2018-06-22 余晓晴 A kind of gynaecology's spray prevented and inhibit HPV viruse
CN108542954A (en) * 2018-05-22 2018-09-18 湖南千金养生坊健康品股份有限公司 A kind of Traditional Chinese medicine gel composition of inhibitory anti-virus
CN109106806A (en) * 2018-06-20 2019-01-01 广州宏韵医药科技股份有限公司 A kind of women secret nursing washing lotion and preparation method thereof
CN108853287A (en) * 2018-08-07 2018-11-23 吉林省正肽生物科技有限公司 Pharmaceutical composition, gel preparation and the application of a kind of anti-human papilloma virus (anti-HPV) and anti-gynaecological imflammation
CN109674903A (en) * 2019-01-29 2019-04-26 罗梦芝 One curing hysteromyoma, uterus adenomyosis, cervical polyp, HPV therapeutic agent

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
孔令义主编: "《天然药物化学》", 31 August 2015 *
张正付等: "鼠尾草属植物化学成分及活性研究新进展" *
张雷红等主编: "《天然药物化学 第3版》", 31 January 2017 *
王磊: "黑桑化学成分及生物活性研究" *
阎冰冰等: "乳酸杆菌对阻断高危型HPV持续性感染作用的前瞻性研究" *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115486538A (en) * 2022-09-14 2022-12-20 广州通泽医疗科技有限公司 Composition with female reproductive system protection effect and preparation method and application thereof
CN115486538B (en) * 2022-09-14 2023-09-15 广州通泽医疗科技有限公司 Composition with female reproductive system protection effect, and preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN111574618B (en) Preparation method of whitening compound protein peptidase hydrolysate, whitening compound protein peptide beverage and preparation method thereof
CN107823095A (en) A kind of active peptide facial mask
CN102085172B (en) Skin care cosmetic taking American wild yam extract as main component and preparation method thereof
CN208279353U (en) A kind of mist small molecule hydrogen-rich water preparation apparatus
CN105639560A (en) Biological-enzymolysis-method sporoderm-broken lucid ganoderma spore powder honey for calming nerves and aiding sleep and production process thereof
CN110201150A (en) A kind of drug increasing the anti-HPV of human body cell activity
CN102972872A (en) Breast enlarging and beautifying anti-sag bra
CN105902477B (en) The comprehensive biological agent and preparation method thereof for improving eye vigor
CN108175024A (en) A kind of sunflower flower powder solid beverage and preparation method
CN109172491A (en) A kind of creme and preparation method thereof with anti-aging and activating microcirculation and removing stasis medicinal function
CN104605226A (en) Healthcare product with function of increasing bone mineral density
CN110916200A (en) Uric acid reducing composition and preparation method thereof
CN106333977A (en) Natural drug composition for treatment of osteoporotic fracture and/or osteoarthritis and application thereof
CN108056964A (en) A kind of U.S.'s chest essential oil composition
CN101735924A (en) Womb warming youth wine
KR20080090808A (en) Composition of healthy food for a skin
CN108030012A (en) A kind of healthy food with body beautification moistening face
CN107823079A (en) A kind of sea cucumber EGF composition skin-care cosmetics and preparation method thereof
CN116212007B (en) Bone-knitting and tendon-softening traditional Chinese medicine composition for treating metaphase fracture and preparation method thereof
CN108355005A (en) A kind of Chinese patent drug for treating the protrasion of the lumbar intervertebral disci
CN104587456A (en) Production process for health product capable of increasing bone mineral density
CN108295016A (en) A kind of chest enlarge gel
CN107375333A (en) Treat intacellin biogel preparation of premature ovarian failure and preparation method thereof
CN102389140A (en) Method for solving compatibility problem of grape seed extract and collagen aqueous solution
CN105056215A (en) Natural traditional Chinese medicine composition and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination